Lund
Sweden
32
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor Ellmark Peter:
Peter Ellmark from Lund, SE has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL PEPTIDES
#2 | 2026-02-26COMBINATION THERAPIES
#3 | 2024-08-29NOVEL COMBINATION THERAPIES AND USES THEREOF
#4 | 2024-07-11COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES
#5 | 2024-04-25COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES
#6 | 2024-04-11PEPTIDES
#7 | 2024-01-04METHODS AND COMPOSITIONS
#8 | 2023-10-05Peptides
#9 | 2023-09-21NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF
#10 | 2022-07-07Bispecific polypeptides against CD137
#11 | 2022-03-10NOVEL POLYPEPTIDES
#12 | 2022-03-03NOVEL POLYPEPTIDES
#13 | 2021-12-30COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES
#14 | 2021-08-05Polypeptides
#15 | 2020-07-16Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods
#16 | 2020-06-18Polypeptides
#17 | 2020-02-13BISPECIFIC ANTIBODY AGAINST OX40 AND CTLA-4
#18 | 2019-12-19Oncofetal antigen binding proteins and related compositions and methods
#19 | 2019-11-21Anti-CD137 antibodies and uses thereof
#20 | 2019-11-21Anti-CD137 antibodies and uses thereof
#21 | 2019-10-10Bispecific Polypeptides to GITR and CTLA-4
#22 | 2019-06-06NOVEL BISPECIFIC POLYPEPTIDES AGAINST CD137
#23 | 2019-05-30Bispecific Antibodies Directed Against OX40 and a Tumor-Associated Antigen
#24 | 2019-01-17Oncofetal antigen binding proteins and related compositions and methods
#25 | 2018-05-03Polypeptides
#26 | 2017-10-26BISPECIFIC MOLECULES CAPABLE OF SPECIFICALLY BINDING TO BOTH CTLA-4 AND CD40
#27 | 2017-08-10Combination therapies with anti CD40 antibodies
#28 | 2017-01-05scFV antibody library
#29 | 2016-10-27Anti-CD40 antibodies
#30 | 2016-10-20CD86 variants with improved affinity for CTLA-4
#31 | 2013-01-03Medical methods and agents for use therein
#32 | 2009-08-13Method for in Vitro Molecular Evolution of Protein Function
10585 ⎘